This is a computer translation of the original webpage. It is provided for general information only and should not be regarded as complete nor accurate. Close Disclaimer
Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Fraud Risk and Heightened Scrutiny

The government's primary civil tool for addressing health care fraud is the False Claims Act (FCA). Most FCA cases are resolved through settlement agreements in the government alleges fraudulent conduct and typically the settling parties do not admit liability. Depending on the facts and circumstances presented, OIG will usually pursue one of the following approaches when settling a health care fraud case: (1) exclusion; (2) heightened scrutiny; (3) integrity obligations; (4) take no further action; or (5) in the case of a good faith and cooperative self-disclosure, release 1128(b)(7) exclusion with no integrity obligations. OIG’s Risk Spectrum illustrates these approaches. For more information on how OIG evaluates risk to the Federal health care programs and the criteria for the OIG considers in evaluating exclusions in False Claims Act cases, see OIG’s April 18, 2016 notice.

A graphic that shows high risk to low risk respectfully: Exclusion; Heightened Scrutiny; CIAs; No Further Action; Self-Disclosure

FY 2024 Q1-Q4

Fraud Risk Spectrum 2023 Q1: 17 exclusions, 2 heightened scrutiny, 29 CIAs, 184 no further action, 7 self-disclosure

Fraud Risk Spectrum 2022 Q1-Q4: 11 exclusions, 1 heightened scrutiny, 37 CIAs, 193 no further action, 6 self-disclosure

Updated Risk Spectrum for 2021 Quarters 1 through 4

Updated Risk Spectrum for 2020 Quarters 1 through 4

Updated 2019 False Claims Act Settlements on the Risk Spectrum

Last updated October 11, 2024